Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DEXCOM INCDXCM · Entity 3114 | SVP Chief Risk Officer | March 08, 2022 | March 11, 2022 |
| iRhythm Holdings, Inc.IRTC · Entity 1499 | EVP, Chief Risk Officer | August 07, 2026 | August 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DEXCOM INC
Report date March 08, 2022 · Filed March 11, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,789 |
Last balance in matching sequence
After 2022-03-09 transaction · row 5
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
5 source rowsRow 1 · 2022-03-08 · Grant · Acquired 2,889 · Balance 15,146 F1: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2: Included in this number are 6,373 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,436 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Row 2 · 2022-03-09 · Disposition to issuer · Disposed 519 · Balance 14,627 F3: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2: Included in this number are 6,373 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,436 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Row 3 · 2022-03-09 · Disposition to issuer · Disposed 192 · Balance 14,435 F3: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2: Included in this number are 6,373 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,436 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Row 4 · 2022-03-09 · Disposition to issuer · Disposed 309 · Balance 14,126 F3: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2: Included in this number are 6,373 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,436 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Row 5 · 2022-03-09 · Disposition to issuer · Disposed 337 · Balance 13,789 F3: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2: Included in this number are 6,373 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,436 of which were granted on March 8, 2020 and shall vest through March 8, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
F2: Included in this number are 6,373 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,436 of which were granted on March 8, 2020 and shall vest through March 8, 2023.
F3: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
iRhythm Holdings, Inc.
Report date August 07, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 44,621 |
Ending reported balance
After 2026-08-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-07 · Grant · Acquired 9,706 · Balance 49,993 F1: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on August 7, 2023. Row 2 · 2026-08-10 · Sale · Disposed 5,372 · Balance 44,621 F2: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on August 7, 2023.
F2: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2026 Filed Aug 11, 2026 20:01 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 5,372 | $124.65 | $669,640.75 |
DisclosureSEC source: 0001850687-26-000010 · wk-form4_1786478483.xml · nonDerivative · entry 2 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,621 F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 20:01 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 9,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001850687-26-000010 · wk-form4_1786478483.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,993 F1 · shares: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on August 7, 2023. Read SEC document |
| June 02, 2026 Filed Jun 3, 2026 20:16 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 1,716 | $108.19 | $185,652.50 |
DisclosureSEC source: 0001850687-26-000008 · wk-form4_1780517759.xml · nonDerivative · entry 2 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,287 F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). Read SEC document |
| May 29, 2026 Filed Jun 3, 2026 20:16 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 133 | $96.82 | $12,876.40 |
DisclosureSEC source: 0001850687-26-000008 · wk-form4_1780517759.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,003 F1 · shares: Ms. Shrishrimal is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2025 through May 31, 2026. This transaction is exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 23:39 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 978 | $128.44 | $125,615.88 |
DisclosureSEC source: 0001850687-26-000006 · wk-form4_1772581162.xml · nonDerivative · entry 3 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,870 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 23:39 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 906 | $128.44 | $116,365.46 |
DisclosureSEC source: 0001850687-26-000006 · wk-form4_1772581162.xml · nonDerivative · entry 2 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,848 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 23:39 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 946 | $128.44 | $121,502.54 |
DisclosureSEC source: 0001850687-26-000006 · wk-form4_1772581162.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,754 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). Read SEC document |
| February 25, 2026 Filed Feb 26, 2026 22:47 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 6,217 | $135.42 | $841,899.30 |
DisclosureSEC source: 0001850687-26-000002 · wk-form4_1772146024.xml · nonDerivative · entry 2 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,182 F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:35 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 5,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001850687-26-000004 · wk-form4_1772228151.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,700 F1 · shares: These securities are Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on March 1, 2027 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 22:47 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 11,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001850687-26-000002 · wk-form4_1772146024.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,399 F1 · shares: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on February 27, 2023. Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 23:23 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 73 | $119.55 | $8,727.33 |
DisclosureSEC source: 0001850687-25-000008 · wk-form4_1764717785.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,105 F1 · shares: Ms. Shrishrimal is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period June 1, 2025 through November 30, 2025. This transaction is exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 22, 2025 Filed Aug 22, 2025 22:27 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 653 | $167.12 | $109,129.36 |
DisclosureSEC source: 0001850687-25-000006 · wk-form4_1755901669.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,032 F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 23, 2025. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 20:18 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 1,608 | $140.21 | $225,457.68 |
DisclosureSEC source: 0001388658-25-000156 · wk-form4_1748981875.xml · nonDerivative · entry 2 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,685 F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:18 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 176 | $71.46 | $12,576.96 |
DisclosureSEC source: 0001388658-25-000156 · wk-form4_1748981875.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,293 F1 · shares: Ms. Shrishrimal is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2024 through May 31, 2025. This transaction is exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:02 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 1,726 | $108.77 | $187,737.02 |
DisclosureSEC source: 0001388658-25-000063 · wk-form4_1741122154.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,117 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units. Read SEC document |
| February 26, 2025 Filed Feb 27, 2025 21:07 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 7,942 | $112.13 | $890,536.46 |
DisclosureSEC source: 0001388658-25-000048 · wk-form4_1740690415.xml · nonDerivative · entry 6 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,843 F6 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs. Read SEC document |
| February 26, 2025 Filed Feb 27, 2025 21:07 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 6,732 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-25-000048 · wk-form4_1740690415.xml · nonDerivative · entry 5 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,785 F5 · shares: These securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on March 1, 2026 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 21:07 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 15,293 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-25-000048 · wk-form4_1740690415.xml · nonDerivative · entry 4 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,053 F4 · shares: Represents the acquisition of shares upon the determination of the Compensation Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on May 24, 2022. Read SEC document |
| November 29, 2024 Filed Feb 27, 2025 21:07 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | OtherCommon Stock | 110 | $71.46 | $7,860.60 |
DisclosureSEC source: 0001388658-25-000048 · wk-form4_1740690415.xml · nonDerivative · entry 3 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,760 F3 · shares: Ms. Shrishrimal is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period June 1, 2024 through November 30, 2024. This transaction is exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 16:40 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 1,131 | $88.91 | $100,557.21 |
DisclosureSEC source: 0001388658-24-000127 · wk-form4_1717605615.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,298 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units. Read SEC document |
| May 31, 2024 Filed Feb 27, 2025 21:07 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | OtherCommon Stock | 186 | $74.98 | $13,946.28 |
DisclosureSEC source: 0001388658-25-000048 · wk-form4_1740690415.xml · nonDerivative · entry 2 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,650 F2 · shares: Ms. Shrishrimal is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2023 through May 31, 2024. This transaction is exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:49 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 723 | $111.14 | $80,354.22 |
DisclosureSEC source: 0001388658-24-000054 · wk-form4_1709675360.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,429 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:18 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 6,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-24-000040 · wk-form4_1709338683.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,152 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on February 28, 2025 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| November 30, 2023 Filed Feb 27, 2025 21:07 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | OtherCommon Stock | 166 | $72.49 | $12,033.34 |
DisclosureSEC source: 0001388658-25-000048 · wk-form4_1740690415.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,464 F1 · shares: Ms. Shrishrimal is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2022 through November 30, 2023. This transaction is exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 02, 2023 Filed Jun 5, 2023 20:07 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 1,109 | $111.45 | $123,598.05 |
DisclosureSEC source: 0001388658-23-000077 · wk-form4_1685995640.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,707 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of restricted stock units. F2 · balance_after: Includes 129 shares acquired under the Issuer's employee stock purchase plan on May 31, 2023. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 23:05 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 6,961 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-23-000014 · wf-form4_167771191606110.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,687 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on March 1, 2024 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. F2 · balance_after: Includes 124 shares acquired under the Issuer's employee stock purchase plan on November 30, 2022. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:30 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 337 | $406.06 | $136,841.11 |
DisclosureSEC source: 0001093557-22-000055 · edgardoc.xml · nonDerivative · entry 5 Shrishrimal Sumi · CIK 0001850687 · SVP Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,789 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 6,373 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,436 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:30 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 309 | $406.06 | $125,471.52 |
DisclosureSEC source: 0001093557-22-000055 · edgardoc.xml · nonDerivative · entry 4 Shrishrimal Sumi · CIK 0001850687 · SVP Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,126 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 6,373 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,436 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:30 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 192 | $406.06 | $77,962.89 |
DisclosureSEC source: 0001093557-22-000055 · edgardoc.xml · nonDerivative · entry 3 Shrishrimal Sumi · CIK 0001850687 · SVP Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,435 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 6,373 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,436 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:30 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 519 | $406.06 | $210,743.43 |
DisclosureSEC source: 0001093557-22-000055 · edgardoc.xml · nonDerivative · entry 2 Shrishrimal Sumi · CIK 0001850687 · SVP Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,627 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 6,373 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,436 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 00:30 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 2,889 | $0.00 | $2.89 |
DisclosureSEC source: 0001093557-22-000055 · edgardoc.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · SVP Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,146 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 6,373 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,436 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:01 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 5 | $542.46 | $2,712.30 |
DisclosureSEC source: 0001093557-21-000219 · edgardoc.xml · nonDerivative · entry 2 Shrishrimal Sumi · CIK 0001850687 · SVP Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,234 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 6,749 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,872 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 804 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:01 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 402 | $541.36 | $217,626.72 |
DisclosureSEC source: 0001093557-21-000219 · edgardoc.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · SVP Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,239 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 6,749 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,872 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 804 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| July 16, 2021 Filed Jul 17, 2021 00:40 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 400 | $450.00 | $180,000.00 |
DisclosureSEC source: 0001093557-21-000179 · edgardoc.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · SVP Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,586 F1 · shares: On November 25, 2020, Ms. Shrishrimal adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Shrishrimal. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 7,553 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,872 of which were granted on March 8, 2020 and shall vest through March 8, 2023 and 1,608 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 22:14 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 400 | $401.09 | $160,436.00 |
DisclosureSEC source: 0001093557-21-000169 · edgardoc.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · SVP Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,986 F1 · shares: On November 25, 2020, Ms. Shrishrimal adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Shrishrimal. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 7,553 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,872 of which were granted on March 8, 2020 and shall vest through March 8, 2023 and 1,608 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| May 25, 2021 Filed May 27, 2021 21:28 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,461 | $354.79 | $518,348.19 |
DisclosureSEC source: 0001093557-21-000157 · edgardoc.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · SVP Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,386 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 7,553 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,872 of which were granted on March 8, 2020 and shall vest through March 8, 2023 and 1,608 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.